Atlas Trials

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital

Clinical trial NCT00321035 · COMPLETED

Trial details

NCT number
NCT00321035
Sponsor
Pro Top & Mediking Company Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
GlaucomaPterygium
Start date
2005-12-01
Primary completion
2008-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.